Success Stories: I-140 NIW Approved for a Researcher from China in Tumor Immunology due to NAILG’s Arbitration
On July 13th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for a Researcher in the field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Researcher
Country of Origin: China
Approval Notice Date: July 13th, 2021
Processing Time: 11 months, 18 days
Case Summary:
Armed with a Postdoctoral Degree, a researcher from China approached NAILG (North America Immigration Law Group) to help her in adjudicating with the USCIS on her behalf. Her proposed endeavor to investigate the underlying epigenetic mechanisms driving autoimmune disease and cancer proliferation in order to identify viable new targets and compounds for drug development to treat these conditions was not only thoroughly researched but also had the potential to transform the US healthcare system. This prompted us to look at her academic and past professional records before countersigning the retainer document.
Her excellent academic and professional record helped us tailor the case to her strengths. We tried to showcase her achievements by putting together a list of publications, citations, and reviews, demonstrating her constant engagement and impact upon other researchers in her field. Her 8 peer-reviewed publications (2 of them first-authored) have been cited a total of 682 times according to Google Scholar, thereby illustrating that these publications are widely recognized and relied upon in the field of immunology. She has thus authored 1 paper that ranks among the top 0.01%%, 1 paper that ranks among the top 0.1%, 1 paper that ranks among the top 1%, 2 papers that rank among the top 10%, and 1 paper that ranks among the top 20% most-cited articles across the entire field for Immunology for their respective years of publication.
Another thing that we take note of at NAILG is the letters of recommendation obtained from dependent and independent experts in the field. With her case some of the recommenders had the following to say about the import of her work to the US and its health care system:
“In the United States, colorectal cancer is the second leading cause of cancer death among men and women combined. In many cases, colorectal cancer is preceded by common inflammatory gastrointestinal diseases like ulcerative colitis and Crohn’s disease. Both of these conditions are characterized as inflammatory bowel diseases, so [the client’s] investigation to understand how to more effectively mitigate inflammation is substantially important to the United States.”
“[The Client’s] evaluation of the mechanisms that incite inflammation, therefore, contributes to her efforts to design treatments for autoimmune diseases and colorectal cancer. In particular, the prevalence of autoimmune diseases nationwide makes [the Client’s]research of specific interest to the United States.”
We would like to thank our client for her confidence in our experience with how USCIS adjudicates in matters of National Interest Waiver (NIW) petition. Thanks to our legal strategies earned over several years of some 25,000+ successful approvals, we were victorious in her case too. We wish her the very best and we are certain that her research will transform the field of immunology.